AUD1.57
11.80% yesterday
Australia, Nov 15, 06:10 am CET
ISIN
AU000000MSB8
Symbol
MSB
Sector
Industry

Mesoblast Target price 2024 - Analyst rating & recommendation

Mesoblast Classifications & Recommendation:

Buy
100%

Mesoblast Price Target

Target Price AUD1.86
Price AUD1.57
Potential
Number of Estimates 4
4 Analysts have issued a price target Mesoblast 2025 . The average Mesoblast target price is AUD1.86. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 6 Analysts recommend Mesoblast to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast stock has an average upside potential 2025 of . Most analysts recommend the Mesoblast stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million AUD 9.01 96.84
19.19% 974.85%
EBITDA Margin -917.43% 4.45%
0.17% 100.49%
Net Margin -1,773.29% -135.29%
8.28% 92.37%

6 Analysts have issued a sales forecast Mesoblast 2025 . The average Mesoblast sales estimate is

AUD96.8m
Unlock
. This is
974.85% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD451m 4,903.80%
Unlock
, the lowest is
AUD9.0m 0.46%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD9.0m 19.19%
2025
AUD96.8m 974.85%
Unlock
2026
AUD364m 275.99%
Unlock
2027
AUD708m 94.46%
Unlock
2028
AUD557m 21.35%
Unlock
2029
AUD976m 75.29%
Unlock

3 Analysts have issued an Mesoblast EBITDA forecast 2025. The average Mesoblast EBITDA estimate is

AUD4.3m
Unlock
. This is
105.21% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD191m 331.42%
Unlock
, the lowest is
AUD-105m 27.48%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD-82.7m 19.06%
2025
AUD4.3m 105.21%
Unlock
2026
AUD96.0m 2,129.39%
Unlock
2027
AUD283m 194.41%
Unlock

EBITDA Margin

2024 -917.43% 0.17%
2025
4.45% 100.49%
Unlock
2026
26.37% 492.58%
Unlock
2027
39.92% 51.38%
Unlock

3 Mesoblast Analysts have issued a net profit forecast 2025. The average Mesoblast net profit estimate is

AUD-131m
Unlock
. This is
18.00% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD-98.7m 38.23%
Unlock
, the lowest is
AUD-173m 8.37%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD-160m 12.50%
2025
AUD-131m 18.00%
Unlock
2026
AUD-50.3m 61.62%
Unlock
2027
AUD50.2m 199.86%
Unlock
2028
AUD31.2m 37.92%
Unlock
2029
AUD336m 977.67%
Unlock

Net Margin

2024 -1,773.29% 8.28%
2025
-135.29% 92.37%
Unlock
2026
-13.81% 89.79%
Unlock
2027
7.09% 151.34%
Unlock
2028
5.60% 21.02%
Unlock
2029
34.41% 514.46%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share AUD -0.14 -0.11
12.50% 21.43%
P/E negative
EV/Sales 19.37

3 Analysts have issued a Mesoblast forecast for earnings per share. The average Mesoblast <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

AUD-0.11
Unlock
. This is
21.43% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
AUD-0.09 35.71%
Unlock
, the lowest is
AUD-0.15 7.14%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD-0.14 12.50%
2025
AUD-0.11 21.43%
Unlock
2026
AUD-0.04 63.64%
Unlock
2027
AUD0.04 200.00%
Unlock
2028
AUD0.03 25.00%
Unlock
2029
AUD0.29 866.67%
Unlock

P/E ratio

Current -11.54 395.28%
2025
-13.68 18.54%
Unlock
2026
-35.64 160.53%
Unlock
2027
35.68 200.11%
Unlock
2028
57.49 61.13%
Unlock
2029
5.33 90.73%
Unlock

Based on analysts' sales estimates for 2025, the Mesoblast stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

19.37
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
18.50
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 208.16 520.63%
2025
19.37 90.70%
Unlock
2026
5.15 73.40%
Unlock
2027
2.65 48.57%
Unlock
2028
3.37 27.15%
Unlock
2029
1.92 42.95%
Unlock

P/S ratio

Current 198.86 619.62%
2025
18.50 90.70%
Unlock
2026
4.92 73.40%
Unlock
2027
2.53 48.58%
Unlock
2028
3.22 27.15%
Unlock
2029
1.84 42.95%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today